Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Cerner And Nuance Expand Collaboration To Embed Nuance Cloud-Based Voice Technology With Cerner’s® Mobile EHR Solutions

Stock quotes in this article: CERN, NUAN 

CERNER HEALTH CONFERENCE--Cerner (NASDAQ: CERN) and Nuance Communications, Inc. (NASDAQ: NUAN) today announced that the companies have expanded their relationship to accelerate the adoption of simpler, faster and smarter healthcare solutions for clinicians worldwide. The expanded partnership reflects both companies’ commitment to providing innovative, proven solutions that keep patient care a top priority by leveraging voice and mobile technologies to optimize clinician workflow and maximize the benefits of electronic health records (EHRs).

Under a new worldwide agreement, Cerner will embed Nuance’s cloud-based medical voice recognition into its full portfolio of mobile EHR solutions – including PowerChart Touch™ that was announced at the Health Information Management Systems Society (HIMSS) conference in February. This integration will create a new class of mobile healthcare solutions on phones and tablets that enable clinicians to capture more complete patient notes, navigate applications and search for information while on-the-go – simply by using their voice.

In addition, Cerner and Nuance announced the availability and integration of Nuance’s radiology reporting suite, PowerScribe 360, with Cerner’s RadNet® Radiology Information System (RIS). This solution is an example of both companies’ ongoing innovation and will allow radiologists to dictate, in real-time, reports that are integrated directly and instantly with the patient record.

“The expansion of our partnership with Nuance, a company that offers voice and clinical understanding solutions used by 450,000 clinicians worldwide, exemplifies our commitment to provide state-of-the-art solutions to customers across the globe,” said Don Bisbee, senior vice president of DeviceWorks at Cerner. “By incorporating Nuance’s voice recognition capabilities into our core clinical applications including our latest mobile solution, PowerChart Touch, we are able to provide the healthcare industry with a simple, fast method of capturing complex medical information within the patient record at the point-of-care.”

PowerChart Touch is a mobile, cloud-based solution that is part of the Millennium+ portfolio. PowerChart Touch offers role and venue-based mobile workflows which allow physicians to perform their job duties straight from a mobile device. PowerChart Touch will provide a true native application experience across an array of platforms. Nuance’s 360 | SpeechAnywhere medical voice recognition solution, the technology that is embedded within PowerChart Touch, is also cloud-based. Together, Cerner and Nuance solutions will help simplify the large scale deployment of these integrated technologies, while also reducing the overall cost of ownership for customers.

“For more than 30 years, Cerner has proven its ability to create digital technologies that solve problems and positively impact patient care. Its most recent mobile innovations are a prime example of how these solutions are transforming the EHR experience today, and a key reason why now is the right time to expand our partnership. Cerner’s solutions are enabling clinicians to experience a fully functional EHR – anytime and anywhere – and voice is playing an important role in making this a reality,” said Janet Dillione, executive vice president and general manager of Nuance Healthcare. “We are excited to expand our partnership and confident that intuitive, voice-enabled technologies with deep Cerner integration will spur further industry innovation, improve the clinician experience and help focus efforts on the core mission – providing quality patient care.”

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,455.54 67.96 0.44%
NASDAQ 3,508.56 6.44 0.18%
S&P 500 1,674.12 4.96 0.30%
US 10 Yr 1.979% +0.035

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs